Kioxia Holdings Corp (285A): UBS sees Kitakami capacity optionality while expecting near-term results to meet guidance

Overview

UBS's plant-visit note examines Kioxia's Kitakami production roadmap, future expansion capacity, and near-term NAND pricing outlook. The firm expects earnings to meet guidance and maintains its Buy rating and ¥126,000 target price.

Core views

UBS reports that Kitakami, one of Kioxia's two main production sites, is progressing through a staged capacity build-out. K1 is already operating at full capacity. At K2, equipment has been installed in half of the facility and installation is under way in the remaining half. K3 has not yet been built, but its output is expected to begin contributing from FY3/30. Company-wide, BiCS8 bit shipments exceeded half of total shipments in March; Kitakami remains centered on BiCS5, with BiCS8 shipments there expected to begin contributing from early 2027. UBS characterizes Yokkaichi as focused on high-bandwidth products such as Super IOPS, while Kitakami emphasizes productivity improvements and high-capacity BiCS10. Kioxia aims for broadly equal bit shipments from the two plants around 2029, when K3 is expected to contribute. The plant tour also suggested further physical expansion optionality. UBS observed vacant land beside K3 that could support a K4 expansion and parking areas that appear to leave room for K5. Each building has two production-line floors; UBS estimates that even at the fastest equipment-installation pace, filling one floor would take 8–10 months and a whole building roughly twice as long. It estimates monthly capacity per building at 110–120K on a BiCS5-equivalent basis or 60–65K on a BiCS8-equivalent basis. Despite this optionality, UBS forecasts combined Yokkaichi and Kitakami capacity declining from 500K/month at end-CY25 to 420K at end-CY26 and 350K at end-CY27. For the July–September period, UBS's existing forecast assumes a 34% quarter-on-quarter increase in average unit prices. It now judges results increasingly likely to be in line with company guidance because Apple, Kioxia's largest customer, has unit prices below the industry average and market-price increases have slowed as long-term agreements have increased. UBS estimates company guidance implies unit prices up 20–30% quarter on quarter. The company also rejected investor speculation that it had indicated Q2 results would miss guidance. On valuation, UBS says the plant-tour impression may be neutral. It estimates a 9.1% cost of equity using an average ROE of 48% for FY3/28–FY3/31, applies a 5.23x PBR, and sets a ¥126,000 target price. UBS retains its 12-month Buy rating. The report shows a ¥53,340 share price on 28 September 2026 and forecast price appreciation of 136.2%, with a 4.9% forecast dividend yield and 141.2% forecast stock return.

Analysis framework

UBS combines observations from the Kitakami site visit with Kioxia's production plans, technology mix, estimated building-level capacity, NAND unit-price assumptions, and customer mix. It then values the shares using price-to-book, informed by an assumed cost of equity and forecast ROE.

Methodology notes

• Valuation methodsPB valuation

  Price-to-book valuation

  UBS applies a 5.23x PBR to derive its ¥126,000 target price.

• Industry AnalysisSupply-demand framework

  NAND capacity and pricing analysis

  The report links plant capacity, technology transition, long-term agreements, and NAND unit-price movements to the near-term earnings outlook.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Kioxia Holdings Corp (285A.T)

  Primary covered company; UBS assesses its production expansion, NAND technology transition, pricing outlook, and valuation.

  Strengths

  K1 is fully operational; K2 installation is advancing; K3, and potentially K4/K5, provide expansion optionality. BiCS8 is already more than half of company-wide bit shipments.

  Weaknesses

  Combined Yokkaichi and Kitakami capacity is forecast to decline through end-CY27.

  Comparison

  Yokkaichi focuses on high-bandwidth products such as Super IOPS, while Kitakami emphasizes productivity and high-capacity BiCS10.

  Risks

  NAND cyclicality, potential price declines after supply-demand equilibrium, weaker AI and semiconductor investment, and uncertainty over technological leadership.

Key data

• K1 operating statusFull capacityKitakami K1 is currently fully utilized.
• K3 output contributionFY3/30Expected start of contribution from the unbuilt K3 facility.
• Estimated monthly capacity per building110–120K BiCS5-equivalent; 60–65K BiCS8-equivalentUBS estimate.
• Combined plant capacity forecast500K/month at end-CY25; 420K at end-CY26; 350K at end-CY27Yokkaichi plus Kitakami forecast.
• July–September average unit-price forecast+34% qoqUBS's current forecast; guidance is estimated to imply +20–30% qoq.
• Cost of equity9.1%Based on average FY3/28–FY3/31 ROE of 48%.
• Target valuation multiple5.23x PBRUsed to set the target price.
• Forecast stock return141.2%Comprises 136.2% forecast price appreciation and 4.9% forecast dividend yield.

Impact & implications

UBS views the plant roadmap as evidence of longer-term expansion capacity and a transition toward newer NAND technologies, while the near-term earnings outcome hinges on unit-price increases that it expects to be consistent with guidance. The firm retains its Buy rating and PBR-based target price.

Risks

• The NAND market is highly cyclical, and prices could decline once supply and demand move toward equilibrium.
• AI-investment or broader semiconductor-investment slowdowns could reduce demand.
• The sustainability of Kioxia's technological advantage is uncertain.
• High profit leverage during periods of price increases creates sensitivity to pricing movements.

What to watch

• Progress of equipment installation at K2 and the timing of K3 construction and contribution from FY3/30.
• The start of BiCS8 shipment contribution from Kitakami in early 2027.
• NAND unit-price changes, long-term-agreement trends, and whether July–September results meet company guidance.
• Potential use of available land for K4 or K5 expansion.